Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3Sarcoma 1Plasma cell 1Myeloid 1Dermatologic 1Classical hematology 1

Conditions

Anemia, Refractory, with Excess of Blasts 36Leukemia 32Myelodysplastic Syndromes 29Leukemia, Myeloid, Acute 27Leukemia, Myelomonocytic, Chronic 23Congenital Abnormalities 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Myeloproliferative Disorders 10Leukemia, Myelomonocytic, Acute 10Blast Crisis 10Leukemia, Monocytic, Acute 9Leukemia, Megakaryoblastic, Acute 9Leukemia, Erythroblastic, Acute 9Leukemia, Myeloid, Accelerated Phase 8Anemia, Refractory 8Myelodysplastic-Myeloproliferative Diseases 7Lymphoma 7Thrombocytopenia 6Leukemia, Myeloid, Chronic-Phase 6Lymphoma, Non-Hodgkin 5Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 5Leukemia, Lymphocytic, Chronic, B-Cell 5Primary Myelofibrosis 4Neoplasms, Plasma Cell 4Multiple Myeloma 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Hodgkin Disease 4

Interventions

Mycophenolic Acid 7fludarabine phosphate 5Tacrolimus 5Cyclosporine 5Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Cyclophosphamide 4Whole-Body Irradiation 3Therapeutics 3Methotrexate 3Melphalan 3Cord Blood Stem Cell Transplantation 3Busulfan 3merphos 2Methylprednisolone 2Filgrastim 2Epoetin Alfa 2Darbepoetin alfa 2Antilymphocyte Serum 2obinutuzumab 1laromustine 1fludarabine 1ferrous sulfate 1ferric gluconate 1Vorinostat 1Valganciclovir 1Transplantation 1Tetradecanoylphorbol Acetate 1Sucrose 1Polymerase Chain Reaction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Hairy Cell × Cytarabine × Classical hematology × Clear all
NCT00281879 2017-09-27

Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer

OHSU Knight Cancer Institute

Phase 2 Terminated
200 enrolled 11 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡